Predictors of response to TNF inhibitors in rheumatoid arthritis: an individual patient data pooled analysis of randomised controlled trials.
Johan Law-WanMarc-Antoine SparfelSophie DerolezNicolas AzzopardiPhilippe GoupilleJacqueline DetertDenis MullemanTheodora Bejan-AngoulvantPublished in: RMD open (2022)
In RA, patients who are more responsive to TNFi are those who are non-obese, have a long disease duration and have a high initial disease activity.
Keyphrases
- rheumatoid arthritis
- disease activity
- ankylosing spondylitis
- systemic lupus erythematosus
- rheumatoid arthritis patients
- end stage renal disease
- juvenile idiopathic arthritis
- ejection fraction
- newly diagnosed
- interstitial lung disease
- adipose tissue
- type diabetes
- metabolic syndrome
- prognostic factors
- electronic health record
- weight loss
- cancer therapy
- case report
- drug delivery
- bariatric surgery
- obese patients
- artificial intelligence
- systemic sclerosis